Hancom Lifecare한컴라이프케어
372910 · KOSPI · ₩372910 · 한컴라이프케어
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
₩1,889
vs the current price (₩1,869)
- Enterprise value
- ₩13B
- Equity value
- ₩52B
- WACC
- 7.4%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Bear / Base / Bull
- Bear
- ₩1,049
- −43.9%
- Base
- ₩1,889
- +1.0%
- Bull
- ₩3,505
- +87.6%
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Margin path
Every year uses the cycle-average margin (2.0%).
Revenue growth
- -2.7%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (-2.7% a year, annual reports), fading to 3% by year 5.
- -1.3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (-2.7% a year, annual reports), fading to 3% by year 5.
- 0.1%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (-2.7% a year, annual reports), fading to 3% by year 5.
- 1.6%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (-2.7% a year, annual reports), fading to 3% by year 5.
- 3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (-2.7% a year, annual reports), fading to 3% by year 5.
Business
- 2%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 5 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 4.1%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: not in the statements, so 80% of capital spending (most spending replaces equipment that wears out).
- 5.1%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- 17.5%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.11%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-28.
- 0.6
How much the share moves when the market moves: 1 means just like the market.
Default: 105 weeks of weekly returns against KOSPI (official index); raw beta 0.18, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.61%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩119B
- Net debt (borrowings and leases − cash and deposits)
- −₩40B
- + Stakes and investments
- ₩15M
- Associates, long-term financial assets and deposits (book value)
- − Minority interests
- ₩695M
- Shares
- 27,674,406
- Share price
- ₩1,869
- Market cap
- ₩52B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2023 | FY2024 | FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩113B | ₩105B | ₩92B | ₩116B | ₩115B | ₩115B | ₩117B | ₩120B |
| Growth | 12.6% | −7.1% | −12.1% | −2.7% | −1.3% | 0.1% | 1.6% | 3.0% |
| EBIT | ₩1.8B | ₩7.5B | −₩727M | ₩2.3B | ₩2.3B | ₩2.3B | ₩2.3B | ₩2.4B |
| EBIT margin | 1.6% | 7.1% | −0.8% | 2.0% | 2.0% | 2.0% | 2.0% | 2.0% |
| After-tax EBIT | ₩1.3B | ₩5.4B | −₩527M | ₩1.7B | ₩1.7B | ₩1.7B | ₩1.7B | ₩1.7B |
| + Depreciation | — | — | — | ₩4.8B | ₩4.7B | ₩4.7B | ₩4.8B | ₩4.9B |
| − Capital spending | ₩5.4B | ₩4.4B | ₩5.9B | ₩5.9B | ₩5.8B | ₩5.9B | ₩5.9B | ₩6.1B |
| − Working capital | ₩52B | −₩9.2B | −₩27B | −₩564M | −₩264M | ₩20M | ₩321M | ₩612M |
| Free cash flow | — | — | — | ₩1.1B | ₩780M | ₩497M | ₩203M | −₩72M |
| Discount factor | — | — | — | 0.931 | 0.867 | 0.807 | 0.751 | 0.700 |
| Present value | — | — | — | ₩1B | ₩676M | ₩401M | ₩153M | −₩50M |
Terminal value ₩16B, worth ₩11B today: 83% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Cross-check: what the market has paid before
For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:
| Low | Typical | High | |
|---|---|---|---|
| Price / book (book value ₩4,755 a share)Now 0.39× | ₩2,1730.46× | ₩4,8011.01× | ₩6,8771.45× |
| P/E on run-rate earnings (Q2 2026 × 4: ₩991 a share)Now 1.89× | ₩13,57913.7× | ₩16,57116.7× | ₩36,53636.9× |
Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2021, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 6.4% | ₩2,009 | ₩2,006 | ₩2,003 | ₩1,998 | ₩1,990 |
| 6.9% | ₩1,954 | ₩1,948 | ₩1,940 | ₩1,930 | ₩1,916 |
| 7.4% | ₩1,907 | ₩1,899 | ₩1,889 | ₩1,875 | ₩1,859 |
| 7.9% | ₩1,868 | ₩1,858 | ₩1,846 | ₩1,832 | ₩1,813 |
| 8.4% | ₩1,834 | ₩1,823 | ₩1,811 | ₩1,795 | ₩1,776 |
Now (TTM)
- Market cap
- ₩52B
- Enterprise value
- ₩12B
- P/E
- —
- P/B
- 0.4×
- P/S
- 0.4×
- EV/EBITDA
- —
- Dividend yield
- 0.0%
Over time (at each year end)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Price | ₩3,015 | ₩3,140 | ₩4,535 | ₩5,850 | ₩8,870 |
| Market cap | ₩83B | ₩87B | ₩126B | ₩162B | ₩245B |
| P/E | — | 11.8× | 152.2× | 17.6× | 50.8× |
| P/B | 0.7× | 0.6× | 1.0× | 1.3× | 2.1× |
| P/S | 0.9× | 0.8× | 1.1× | 1.6× | 2.0× |
| EV/EBITDA | — | — | — | — | — |
| Dividend yield | 0.0% | — | — | — | — |
Versus similar companies
| Company | P/E | P/B | P/S | EV/EBITDA | Dividend yield |
|---|---|---|---|---|---|
| Hancom Lifecare | — | 0.4× | 0.4× | — | 0.0% |
| TSE | 27.5× | 6.1× | 5.1× | — | 0.2% |
| Kctech | 20.8× | 3.2× | 3.8× | 16.1× | 0.5% |
| Classys | 12.6× | 3.1× | 4.7× | 9.8× | 3.8% |
| Park Systems | 68.1× | 4.6× | 8.1× | — | 0.2% |
| Curiox Biosystems | — | 21.9× | 187.1× | — | 0.0% |
| DI | 36.7× | 5.0× | 2.2× | — | 0.7% |
| Similar companies (median) | 27.5× | 4.8× | 4.9× | 13.0× | 0.4% |
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: Hancom Lifecare / 한컴라이프케어 / 372910 / KRX:372910
Source: KRX statistical information